ロード中...
Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
BACKGROUND: This phase II trial was designed to assess the response rate, survival benefits and toxicity profile of temozolomide, and brain reirradiation using conformal radiotherapy (CRT) for recurrent grade II brain glioma. Between February 2006 and June 2009, 18 patients with recurrent low grade...
保存先:
| 出版年: | World J Oncol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elmer Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649814/ https://ncbi.nlm.nih.gov/pubmed/29147389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon838w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|